Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Name: Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study
SKU: 2882
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 1 Articles Tags: attention-deficit-disorder-with-hyperactivity, chronic, fatigue-syndrome, fibromyalgia, joel-l-young, judith-c-redmond, myofascial-pain-syndromes, pain, psychopharmacology, psychotropic-drugs

Description

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Description

Joel L. Young, MD

COMPLICATED CASE HISTORIES

Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Joel L. Young, MD and Judith C. Redmond, MA

Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing

Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials

Joel L. Young, MD: Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Description

Joel L. Young, MD

COMPLICATED CASE HISTORIES

Fibromylagia, Chronic Fatigue, and Adult Attention Deficit Hyperactivity Disorder in the Adult: A Case Study

Joel L. Young, MD and Judith C. Redmond, MA

Related products

Psychopharmacology Bulletin VOL 47 No. 2, 2017 – Full Issue Stacked PDF

Alisa B. Busch – Bipolar-I Patient Characteristics Associated with Differences in Antimanic Medication Prescribing

Sophie Robert, PharmD – An Open-Label Assessment of Aripiprazole in the Treatment of PTSD

Daniel J. Carlat, MD: Commentary on the Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials